🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhongyun Dong

Integrated Chinese Medicine (China)

ORCID: 0000-0003-3906-301X

Materials ScienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptor‑mediated signaling”.

Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptor‑mediated signaling

International Journal of Oncology(2021)10.3892/ijo.2021.5221

N/A

0DataRank · unranked

10 citations

Zhongyun Dong, Shan Lu

Antiandrogen Therapy Radiosensitizes Androgen Receptor–Positive Cancers to 18F-FDG

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262958

N/A

0DataRank · unranked

9 citations

Henry B. Spitz, Mary C. Mahoney, Zhongyun Dong, Nalinikanth Kotagiri, Indulekha Singaravelu

Data from Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer

(2023)10.1158/0008-5472.c.6498122.v1

N/A

0DataRank · unranked

0 citations

Jun Qin Mo, Qiande Hu, Gregory P. Boivin, Linda Levin, Shan Lu +3 more

Targeting PCNA/AR interaction inhibits AR-mediated signaling in castration resistant prostate cancer cells

Oncotarget(2025)10.18632/oncotarget.28722

N/A

0DataRank · unranked

1 citations

Zhongyun Dong, Shan Lu